Adrenomed AG
ADRENOMED AG
23/06/2022 09:00
Adrenomed appoints Dr. med. Steffen Stürzebecher as Chief Medical Officer
Lire la news
Voir tous les communiqués de Adrenomed AG
ADRENOMED AG
11/04/2022 09:00
PEI Regulatory Approval Received for Government Funded Clinical Trial Investigating Adrenomed's Adrecizumab in Treating Endothelial Barrier Dysfunction in Hospitalized COVID-19 Patients
Lire la news
Voir tous les communiqués de Adrenomed AG
ADRENOMED AG
15/03/2022 11:00
Adrenomed Supervisory Board appoints Dr. Richard Jones as CEO
Lire la news
Voir tous les communiqués de Adrenomed AG
ADRENOMED AG
02/12/2021 11:30
Adrenomed Receives Positive EMA Scientific Advice for Further Clinical Development of Adrecizumab in Septic Shock
Lire la news
Voir tous les communiqués de Adrenomed AG
ADRENOMED AG
30/08/2021 16:57
Adrenomed: Participation in Upcoming Scientific and Industry Events
Lire la news
Voir tous les communiqués de Adrenomed AG
1
